Fitting mSMART Into Management of Waldenström Macroglobulinemia

To the Editor We read with interest the article outlining the 2016 mSMART guidelines for the diagnosis and management of Waldenström macroglobulinemia (WM). We believe that this is a unique opportunity to emphasize important differences that exist with WM therapy.

from Cancer via ola Kala on Inoreader http://ift.tt/2EwhLRg
via IFTTT